Investor Relations

CORPORATE PROFILE
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics utilizes its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair.
Corporate Presentation
Share Price

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Media & IR Contact
Investor Contact

Kimberly Minarovich
Argot Partners
[email protected]

Media Contact

David Rosen
Argot Partners
[email protected]